The frequency of NOTCH1 variants in T-acute lymphoblastic leukemia/lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma among Jordanian patients.


Journal

Annals of diagnostic pathology
ISSN: 1532-8198
Titre abrégé: Ann Diagn Pathol
Pays: United States
ID NLM: 9800503

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 16 12 2018
revised: 13 01 2019
accepted: 21 01 2019
pubmed: 6 2 2019
medline: 31 10 2019
entrez: 6 2 2019
Statut: ppublish

Résumé

The transmembrane receptor NOTCH1 is thought to be associated with the development and progression of T-acute lymphoblastic leukemia (T-ALL)/T-lymphoblastic lymphoma (T-LBL) and chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL). The current study aimed to characterize NOTCH1 expression and elucidate the variants in the functional PEST domain of the receptor in T-ALL/LBL and CLL/SLL. The nuclear expression of NOTCH1 protein was detected in 25% and 5% of cases of T-ALL/LBL and CLL/SLL, respectively, whereas cytoplasmic expression was detected in 33.3% and 15% cases, respectively. The frequency of variants in T-ALL/LBL was 33%, whereas 40% of CLL/SLL cases possessed variants. Four novel variants were identified; three of which were non-synonymous and one common variant c.7280_7280delG between T-ALL/LBL and CLL/SLL cases. The previously described variant, c.7541_7542delCT, was detected in 3 cases of CLL/SLL. These results provide support for the contribution of NOTCH1 in the etiology of these types of cancers.

Identifiants

pubmed: 30718223
pii: S1092-9134(18)30389-7
doi: 10.1016/j.anndiagpath.2019.01.004
pii:
doi:

Substances chimiques

NOTCH1 protein, human 0
Receptor, Notch1 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

53-58

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Nezeen Z Abualhaj (NZ)

Department of Pathology, Microbiology and Forensic Medicine, School of Medicine, The University of Jordan, Amman, Jordan.

Zain Dardas (Z)

Department of Pathology, Microbiology and Forensic Medicine, School of Medicine, The University of Jordan, Amman, Jordan.

Belal Azab (B)

Department of Pathology, Microbiology and Forensic Medicine, School of Medicine, The University of Jordan, Amman, Jordan; Cell Therapy Center, The University of Jordan, Amman, Jordan.

Dema Ali (D)

Cell Therapy Center, The University of Jordan, Amman, Jordan.

Maher A Sughayer (MA)

Department of Pathology, King Hussein Cancer Center, Amman, Jordan.

Tariq N Aladily (TN)

Department of Pathology, Microbiology and Forensic Medicine, School of Medicine, The University of Jordan, Amman, Jordan.

Mamoun Ahram (M)

Department of Physiology and Biochemistry, School of Medicine, The University of Jordan, Amman, Jordan. Electronic address: m.ahram@ju.edu.jo.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH